Stabilizing A Vascularized Autologous Matrix with Flexible Magnesium Scaffolds to Reconstruct Dysfunctional Left Ventricular Myocardium in a Large-Animal Feasibility Study.
Tobias SchillingSerghei CebotariTim KaufeldIgor TudoracheGudrun BrandesDagmar HartungFrank WackerMichael BauerAxel HaverichThomas HasselPublished in: Journal of functional biomaterials (2023)
The surgical reconstruction of dysfunctional myocardium is necessary for patients with severe heart failure. Autologous biomaterials, such as vascularized patch materials, have a regenerative potential due to in vivo remodeling. However, additional temporary mechanical stabilization of the biomaterials is required to prevent aneurysms or rupture. Degradable magnesium scaffolds could prevent these life-threatening risks. A left ventricular transmural defect was reconstructed in minipigs with a piece of the autologous stomach. Geometrically adaptable and degradable scaffolds made of magnesium alloy LA63 were affixed on the epicardium to stabilize the stomach tissue. The degradation of the magnesium structures, their biocompatibility, physiological remodeling of the stomach, and the heart's function were examined six months after the procedure via MRI (Magnetic Resonance Imaging), angiography, µ-CT, and light microscopy. All animals survived the surgery. Stable physiological integration of the stomach patch could be detected. No ruptures of the grafts occurred. The magnesium scaffolds showed good biocompatibility. Regenerative surgical approaches for treating severe heart failure are a promising therapeutic alternative to the currently available, far from optimal options. The temporary mechanical stabilization of viable, vascularized grafts facilitates their applicability in clinical scenarios.
Keyphrases
- tissue engineering
- heart failure
- left ventricular
- magnetic resonance imaging
- contrast enhanced
- computed tomography
- bone marrow
- cardiac resynchronization therapy
- cell therapy
- high resolution
- optical coherence tomography
- minimally invasive
- hypertrophic cardiomyopathy
- atrial fibrillation
- platelet rich plasma
- early onset
- acute myocardial infarction
- acute heart failure
- stem cells
- climate change
- mitral valve
- left atrial
- human health
- mesenchymal stem cells
- high throughput
- coronary artery bypass
- risk assessment
- magnetic resonance
- acute coronary syndrome
- coronary artery disease
- drug induced
- high speed
- single molecule
- aortic stenosis
- label free